MENU
ALVO
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Alvotech (ALVO) Ownership - Who owns Alvotech?
Alvotech is an integrated biopharmaceutical company committed to developing and manufacturing high-quality biosimilar medicines for patients globally... Show more
Profile
Industry
N/A
Address
9, rue de Bitbourg
Phone
+352 4224500
Employees
999
Web
https://www.alvotech.com
Details
Group
Domestic Stock Funds
Category
Pharmaceuticals
Capitalization
2.5B
P/E Ratio
34.89
Total Cash
38.54M
Projected Growth
N/A
Total Debt
1.23B
Revenue
585.6M
Risk (Beta)
-0.06
Dividend Yield
N/A
Total Cash/Share
0.12
Total Debt/Equity
N/A
Revenue/Share
1.96 USD as % of share price
Fundamentals
ALVO
Capitalization
2.5B
P/E Ratio
34.89
Risk (Beta)
-0.06
Dividend Yield
N/A
Total Cash
38.5M
Total Cash/Share
0.12
Total Debt
1.23B
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
1.96%
Revenue
586M
ROE
N/A
Book Value
-302.29M
P/B Ratio
N/A
Cash Flow
N/A
Earnings
0.41
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
2.83M
Current Ratio
1.73
Current Revenue Per Employee
128648.26
Dividends Per Share - Security
N/A
EBITDA
139M
Float
N/A
Float - Current
N/A
Gross Income Margin
50.70
Revenue To Assets
8.37
Shares Held By Institutions
261M
Shares Outstanding - Current
312M
Total Liabilities
1.55B
Total Volume MTD
N/A
Value
N/A
Gain YTD
-39.342
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. ALVO showed earnings on August 13, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information
General Information
Industry PharmaceuticalsGeneric
Profile
Fundamentals
Details
Industry
N/A
Address
9, rue de Bitbourg
Phone
+352 4224500
Employees
999
Web
https://www.alvotech.com